In patients with SSc-ILD, the expression of EDN1 is increased in lung tissues, and the blockade of EDN1 could be an effective method to limit the progression of lung fibrosis (Abraham et al., 1997; Swigris and Brown, 2010). The gene discussed is EDN1; the disease is pulmonary fibrosis.